1jp5
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:1jp5.jpg|left|200px]] | + | [[Image:1jp5.jpg|left|200px]] |
- | + | ||
- | '''Crystal structure of the single-chain Fv fragment 1696 in complex with the epitope peptide corresponding to N-terminus of HIV-1 protease''' | + | {{Structure |
+ | |PDB= 1jp5 |SIZE=350|CAPTION= <scene name='initialview01'>1jp5</scene>, resolution 2.70Å | ||
+ | |SITE= | ||
+ | |LIGAND= | ||
+ | |ACTIVITY= | ||
+ | |GENE= | ||
+ | }} | ||
+ | |||
+ | '''Crystal structure of the single-chain Fv fragment 1696 in complex with the epitope peptide corresponding to N-terminus of HIV-1 protease''' | ||
+ | |||
==Overview== | ==Overview== | ||
Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
- | 1JP5 is a [ | + | 1JP5 is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1JP5 OCA]. |
==Reference== | ==Reference== | ||
- | Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody., Rezacova P, Lescar J, Brynda J, Fabry M, Horejsi M, Sedlacek J, Bentley GA, Structure. 2001 Oct;9(10):887-95. PMID:[http:// | + | Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody., Rezacova P, Lescar J, Brynda J, Fabry M, Horejsi M, Sedlacek J, Bentley GA, Structure. 2001 Oct;9(10):887-95. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11591344 11591344] |
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
Line 23: | Line 32: | ||
[[Category: hiv pr inhibiting antibody]] | [[Category: hiv pr inhibiting antibody]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 12:06:26 2008'' |
Revision as of 10:06, 20 March 2008
| |||||||
, resolution 2.70Å | |||||||
---|---|---|---|---|---|---|---|
Coordinates: | save as pdb, mmCIF, xml |
Crystal structure of the single-chain Fv fragment 1696 in complex with the epitope peptide corresponding to N-terminus of HIV-1 protease
Overview
BACKGROUND: Since the demonstration that the protease of the human immunodeficiency virus (HIV Pr) is essential in the viral life cycle, this enzyme has become one of the primary targets for antiviral drug design. The murine monoclonal antibody 1696 (mAb1696), produced by immunization with the HIV-1 protease, inhibits the catalytic activity of the enzyme of both the HIV-1 and HIV-2 isolates with inhibition constants in the low nanomolar range. The antibody cross-reacts with peptides that include the N terminus of the enzyme, a region that is highly conserved in sequence among different viral strains and that, furthermore, is crucial for homodimerization to the active enzymatic form. RESULTS: We report here the crystal structure at 2.7 A resolution of a recombinant single-chain Fv fragment of mAb1696 as a complex with a cross-reactive peptide of the HIV-1 protease. The antibody-antigen interactions observed in this complex provide a structural basis for understanding the origin of the broad reactivity of mAb-1696 for the HIV-1 and HIV-2 proteases and their respective N-terminal peptides. CONCLUSION: A possible mechanism of HIV-protease inhibition by mAb1696 is proposed that could help the design of inhibitors aimed at binding inactive monomeric species.
About this Structure
1JP5 is a Protein complex structure of sequences from Mus musculus. Full crystallographic information is available from OCA.
Reference
Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody., Rezacova P, Lescar J, Brynda J, Fabry M, Horejsi M, Sedlacek J, Bentley GA, Structure. 2001 Oct;9(10):887-95. PMID:11591344
Page seeded by OCA on Thu Mar 20 12:06:26 2008